Clinical Trial Update: Implications of Circadian Variation of Human Endocannabinoid Levels on Obesity Risk [NA]

View source ↗

Summary

The clinical trial NCT03000803 evaluating circadian variation of endocannabinoid levels and obesity risk has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: University of Chicago | Conditions: Obesity | NA | Status: WITHDRAWN